Healthcare Letter of Intent Template for Pilot Deals
A meaningful healthcare letter of intent names a specific department, a named signer with budget authority, the pilot's scope and success criteria, a start date, and the conditions under which the pilot converts to a paid contract. Anything less — a vague "we're interested in exploring this" — is a compliment, not evidence.
Quick Answer: A healthcare LOI is only as strong as its commitment clause. Look for a named signer, a specific department and use case, a start date within a defined window, explicit conditions precedent (IRB, security review, EHR integration scope), and language describing what happens if the pilot succeeds. An LOI without those five elements is a warm lead wearing a legal document's clothes.
Healthcare buyers are professionally polite and procedurally slow. A clinical director who tells you "this looks promising, send something over" is being honest and also giving you nothing you can show an investor or a co-founder as proof of demand. The letter of intent exists to convert that politeness into a document with a name, a date, and a condition attached to it. This post gives you the template, explains why each clause matters, walks through a filled example for a specialty clinic pilot, and tells you when an LOI is enough evidence and when it isn't.
The Template Itself
Copy this structure into your own letterhead or a shared document. Every bracketed field is a decision you or the counterparty needs to make explicitly — don't leave any of them as boilerplate.
LETTER OF INTENT — PILOT PROGRAM
Between: [Health System / Practice / Clinic Legal Name]
And: [Startup Legal Name]
Date: [Date]
1. PURPOSE
[Health System Name] and [Startup Name] intend to conduct a pilot
program to evaluate [specific product/service] within
[named department, service line, or patient population].
2. SCOPE OF PILOT
- Department(s): [e.g., Cardiology, Care Coordination, Revenue Cycle]
- Patient / user population: [e.g., 200 post-discharge cardiac patients]
- Duration: [e.g., 90 days from Effective Date]
- Locations: [e.g., Main campus, two affiliated clinics]
3. SUCCESS CRITERIA
The pilot will be evaluated against the following criteria, to be
mutually agreed upon in a pilot statement of work within
[X business days] of this letter:
- [Metric 1, e.g., reduction in readmission-related outreach calls]
- [Metric 2, e.g., clinician-reported time saved per encounter]
- [Metric 3, e.g., patient-reported satisfaction score threshold]
4. CONDITIONS PRECEDENT
This pilot is contingent on the following, to be completed before
the pilot start date:
- [ ] Business Associate Agreement (BAA) executed
- [ ] Security / HIPAA compliance review passed
- [ ] IRB review or exemption determination (if applicable)
- [ ] IT/EHR integration scope confirmed
- [ ] Budget approval from [named signer / committee]
5. RESOURCES AND RESPONSIBILITIES
[Health System Name] will provide: [staff time, data access,
clinical champion, patient recruitment support]
[Startup Name] will provide: [software, training, support,
implementation staff]
6. COMMERCIAL INTENT
If the pilot meets the success criteria in Section 3, the parties
intend to negotiate a [term length] paid agreement at
[pricing structure or "mutually agreed pricing"], subject to
[Health System]'s standard procurement process.
7. NON-BINDING EFFECT
This Letter of Intent expresses the parties' good-faith intent to
proceed as described above. It does not constitute a binding
commitment to purchase, and either party may withdraw before
execution of a definitive pilot agreement. Sections 8 and 9
(Confidentiality and Exclusivity) are binding regardless.
8. CONFIDENTIALITY
Both parties agree to keep pilot terms, clinical data, and
performance results confidential, except as required for
[Startup Name]'s use in investor or board reporting in aggregate,
non-identifying form.
9. EXCLUSIVITY (optional)
For the duration of this letter, [Health System Name] agrees not
to enter a competing pilot with a directly competing vendor for
[specific use case] without written notice to [Startup Name].
Signed:
_______________________ _______________________
[Name, Title] [Name, Title]
[Health System] [Startup Name]
Date: __________ Date: __________
Keep the whole document to two pages. A longer LOI starts to look like the contract it explicitly isn't, and healthcare legal teams will route it to a slower review queue for exactly that reason.
Field-By-Field: Commitment Strength By Clause
Not every clause carries equal weight as evidence. Some are procedural boilerplate; others are the actual signal an investor or a skeptical co-founder should look for. Weigh the letter by what's filled in, not by whether a signature exists.
| Clause | What weak looks like | What strong looks like | Why it matters |
|---|---|---|---|
| Signer | Generic "on behalf of the department" | Named individual with a title that implies budget authority (e.g., VP of Care Coordination) | A signature from someone without authority is unenforceable goodwill, not commitment |
| Scope | "Explore potential applications" | Named department, patient population size, specific use case | Vague scope means no one has actually agreed to anything measurable |
| Success criteria | Absent, or "to be determined later" | 2-3 named metrics with a timeframe to define thresholds | Without criteria, "pilot succeeded" is whoever's opinion wins the room |
| Timeline | No start date | Specific start date or a bounded window ("within Q3") | An LOI with no date is a hope, not a plan |
| Conditions precedent | None listed | BAA, security review, IRB, budget approval explicitly named | Naming the real blockers up front prevents a pilot that stalls in legal for months |
| Commercial intent | Silent on what happens after the pilot | Names a term length and pricing approach, even if non-binding | Signals the buyer has thought past the free trial |
| Exclusivity | Absent | Present, time-bound, scoped to the specific use case | The strongest voluntary signal a buyer can give without a signature on a contract |
A one-page LOI with a named signer, a real department, and explicit conditions precedent is stronger evidence than a five-page LOI stuffed with generic language and no start date. Length is not the signal — specificity is.
Filled Example: LOI For A Specialty Clinic Pilot
Here's how the template looks filled out for a hypothetical early-stage remote monitoring startup piloting with a mid-size cardiology practice. Treat every value below as illustrative, not a benchmark to hit.
Purpose: Riverside Cardiology Associates and [Startup] intend to conduct a pilot to evaluate [Startup]'s post-discharge remote monitoring platform within the practice's heart failure management program.
Scope: Cardiology department, approximately 150 post-discharge heart failure patients over a 90-day pilot, delivered across the practice's two clinic locations.
Success criteria: A reduction in unplanned follow-up calls initiated by care coordinators, clinician-reported time saved per patient check-in, and a patient-reported ease-of-use score collected via a short post-pilot survey — thresholds to be defined jointly within ten business days of signing.
Conditions precedent: BAA executed, security review completed by the practice's IT vendor, and budget sign-off from the practice's managing partner, all required before the pilot start date.
Commercial intent: If success criteria are met, the parties intend to negotiate a 12-month subscription agreement at per-patient pricing, subject to the practice's standard vendor approval process.
Signed by: The practice's managing partner (not a resident or a mid-level clinician who requested the pilot informally) — this is the detail that turns a friendly conversation into evidence a due-diligence reader will actually credit.
Notice what's absent: no dollar figure is locked in, no binding purchase obligation exists, and either party can walk away before a definitive agreement. That's by design — an LOI's job is to prove intent exists, not to substitute for the pilot agreement itself. For the document that turns this LOI into an actual pilot with statements of work and timelines, see the hospital pilot proposal template, which picks up exactly where this letter leaves off.
LOI vs. MOU vs. Pilot Contract
Founders often use these three terms interchangeably, which causes real confusion when a buyer's legal team pushes back on what you sent them. They sit on a spectrum from least to most binding, and each is appropriate at a different stage of the sales conversation.
| Document | Binding? | Typical use | Legal review time | What it proves |
|---|---|---|---|---|
| Letter of Intent (LOI) | No (except confidentiality/exclusivity clauses) | Early commitment signal before a full pilot is scoped | Days to a couple weeks | A named decision-maker is willing to put something in writing |
| Memorandum of Understanding (MOU) | Usually no, sometimes partially | Multi-department or multi-organization alignment on shared goals | Similar to an LOI, sometimes longer if multiple signers | Cross-functional alignment exists, not just one champion |
| Pilot / Services Contract | Yes | Defines deliverables, payment (if any), data handling, liability | Weeks to months, often the slowest step | Actual legal obligation and, often, actual revenue |
The practical implication: don't wait for a signed contract to start telling your validation story, and don't oversell an LOI as if it were one. An LOI is real evidence of demand — a signed pilot contract, especially a paid one, is stronger evidence still. If your current evidence base is thinner than an LOI — a warm intro, an unreturned email, a "sounds interesting" in a hallway conversation — treat this document as the next milestone to chase, not something you can claim you already have. For where an LOI fits inside a full evidence ladder, see the complete guide to startup idea validation.
Alexander Osterwalder and David Bland make this same point structurally in Testing Business Ideas: evidence exists on a strength spectrum, and the test is choosing the cheapest experiment that still produces evidence strong enough for the decision you're about to make. A verbal "yes" costs you a conversation. A signed LOI costs a follow-up meeting and a template. A paid pilot costs weeks of implementation work. Match the evidence you chase to the size of the bet you're about to place — don't skip straight to the most expensive proof when a cheaper one would settle the question.
When An LOI Is (And Isn't) Enough
An LOI is enough when you're deciding whether to keep building toward a specific buyer segment, when you're raising a pre-seed round where investors expect intent signals rather than revenue, or when you're prioritizing which of several conversations to invest more sales time in. It is not enough when you're forecasting revenue for a board deck, when you're making a hiring decision that assumes the deal closes, or when the LOI itself has no named signer, no date, and no conditions precedent — at that point it's closer to a testimonial than a commitment.
Healthcare buying cycles run long relative to almost every other B2B vertical, largely because of the review layers baked into Section 4 of the template above — security, compliance, IRB, budget. An LOI doesn't shortcut those layers; it names them so nobody discovers them for the first time three weeks before the pilot was supposed to start. If you're validating within a broader healthcare go-to-market motion, the buyer landscape sitting behind this document — who actually holds budget authority across a hospital or health system — is covered in the healthcare customer, provider, patient, and payer map.
Key Takeaways
- A meaningful LOI names a person, a date, and a condition — not just a department's general enthusiasm.
- The signer's title matters more than the letter's length. A short LOI signed by someone with real budget authority outweighs a long one signed by a mid-level advocate.
- Success criteria belong in the LOI itself, even if the exact thresholds get finalized in a follow-up statement of work — an LOI with no criteria has no way to be judged "successful."
- Conditions precedent (BAA, security review, IRB, budget sign-off) should be named explicitly, so they surface before the pilot start date instead of stalling it.
- An LOI, an MOU, and a pilot contract are different strengths of evidence — know which one you actually have before you describe it to an investor.
- Exclusivity is the strongest non-binding signal available — a buyer who agrees not to pilot a competitor is telling you something a signature alone doesn't.
- Match the cost of your evidence to the size of your decision, the core discipline behind Testing Business Ideas — don't chase a paid pilot contract when an LOI would already answer the question in front of you.
Frequently Asked Questions
Is a letter of intent legally binding in healthcare deals?
Generally no — most of the document (scope, success criteria, commercial intent) is explicitly non-binding, which is what lets it move faster through legal review. Confidentiality and exclusivity clauses, if included, are typically the exception and are treated as binding even inside an otherwise non-binding letter.
How do I get a hospital or clinic to sign an LOI?
Ask after you've had at least one substantive conversation with a named decision-maker, not a first meeting. Bring a filled-in draft rather than a blank template — most healthcare contacts will edit a document faster than they'll write one from scratch, and a draft signals you've already thought through scope and conditions.
What's the difference between an LOI and a term sheet?
A term sheet is used in investment or M&A contexts and typically includes specific financial terms (valuation, equity, investment amount) that both sides intend to honor once definitive documents are signed. An LOI in a sales context is looser — it signals intent to proceed toward a pilot or contract, without locking in pricing or deliverables yet.
Can I use an LOI as proof of revenue on a pitch deck?
No — an LOI is proof of intent, not proof of revenue, and presenting it as revenue is the kind of inflation that damages credibility the moment an investor asks a follow-up question. List it separately as a pipeline or validation signal ("3 signed LOIs, 1 paid pilot") so the distinction is visible rather than blurred.